<DOC>
<DOCNO>
EP-0000651
</DOCNO>
<TEXT>
<DATE>
19790207
</DATE>
<IPC-CLASSIFICATIONS>
A61K-38/16 A61K-38/17 C07K-14/435 C08L-35/00 B01D-15/04 C07K-14/745 C12N-9/64 A61K-38/43 <main>A61K-35/16</main> A61K-38/48 A61K-35/14 A61K-38/00 C07G-17/00 A61K-35/16 
</IPC-CLASSIFICATIONS>
<TITLE>
method of separating a factor ix preparation from blood plasma.
</TITLE>
<APPLICANT>
monsanto cous<sep>monsanto company<sep>monsanto company800 north lindbergh boulevardst. louis missouri 63167us<sep>monsanto company <sep>
</APPLICANT>
<INVENTOR>
delente jacques jean joseph<sep>schoenfeld richard alan<sep>delente, jacques jean joseph<sep>schoenfeld, richard alan<sep>delente, jacques jean joseph7300 westmorelandst. louis missouri 63130us<sep>schoenfeld, richard alan13454 land-o-woods drivest. louis missouri 63141us<sep>delente, jacques jean joseph<sep>schoenfeld, richard alan<sep>delente, jacques jean joseph7300 westmorelandst. louis missouri 63130us<sep>schoenfeld, richard alan13454 land-o-woods drivest. louis missouri 63141us<sep>
</INVENTOR>
<ABSTRACT>
a blood coagulation factor ix preparation is separated  from plasma by selective adsorption of factors ii, ix and x, to  the substantial exclusion of factors vii and viii, with 0. 025-0,1%  by weight of a water-insoluble, crosslinked polyelectrolyte  copolymer of ethylene and maleic anhydride containing  pendant diloweralkylaminoloweralkyl functional groups.  
</ABSTRACT>
</TEXT>
</DOC>
